Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.
WHAT THE NZX 50 INDEX IS DOING
The NZX50 ended the last trading day of the week basically flat, finishing with a -1.5% decline over the past five days. Year-on-year, the index remains up +3.5%.
THE MAIN GAINERS
30 companies closed higher today, led by Ryman Healthcare (RYM, #18), which gained +4%. Despite today's rise, Ryman's share price declined -3% over the week and remains down -31% year-on-year. a2 Milk (ATM, #9) was also among the top gainers, rising +2% today and +1.5% for the week. a2 has shown strong momentum in the last six months, climbing +51% and currently sitting +40% higher year-on-year. Vulcan Steel (VSL, #26) gained +1.5%, bringing its year-on-year increase to +6%, while Vista Group (VGL, #32) added +1% today. Vista saw a strong +5% gain this week, now up +119% year-on-year.
Ryman Healthcare
Select chart tabs
THE MAIN DECLINERS
On the downside, all 50 decliners closed lower. Kathmandu Brands (KMD, #50) led the losses, down -3% today and -29% year-on-year. Vector (VCT, #11) also fell -3% today, though it remains +7% higher over the year. Hallenstein Glassons (HLG, #43) dropped -2.5%, extending its five-day decline to -3%. However, HLG has gained +24% in the last six months and +28% year-on-year. Heartland Group Holdings (HGH, #33) lost -2% today, sitting at -39% year-on-year.
Kathmandu
Select chart tabs
SMARTSHARES EFTs
| 1-day | 5-day | 6-month | YTD | 1Y | |
| NZ Top 50 ETF (FNZ) | -0.2% | -1.7% | -2.7% | -4.6% | -0.1% |
| NZ Top 10 ETF (TNZ) | -0.3% | -2.5% | -8.2% | -10.8% | -1.5% |
| S/P NZX50 ETF (NZG) | -0.4% | -2.4% | -4.8% | -6.7% | +0.7% |
| NZ Dividend ETF (DIV) | -0.9% | -0.5% | -5.6% | -4.8% | -4.8% |
KEY ANNOUNCEMENTS
The Takeovers Panel has ordered Empire Technology to reimburse Vital Limited (NZX: VTL) $247,036 for takeover-related expenses after Empire failed to pay or acknowledge the costs. Empire had also filed High Court proceedings seeking to avoid reimbursement and claim its own expenses, but the case has not progressed. Vital welcomes the ruling, affirming its compliance with obligations.
No chart with that title exists.
Click on the chart title to find more about this sector, including its components.
We welcome your comments below. If you are not already registered, please register to comment.
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.